Real-world evidence (RWE) is increasingly being sought and used for supporting medical device safety and effectiveness decision making.
In many cases a traditional clinical trial or registry may be too impractical, too time consuming, or too costly for answering device safety, effectiveness, and value questions. And, understanding what constitutes high-quality RWE programs for different stakeholders may seem confusing and overwhelming.
Join Dr. Richard Gliklich, CEO of OM1, for a webinar exploring:
- The Opportunity for RWE under 21 Century Cures and new device regulatory guidance;
- Understanding quality in registries and RWE;
- Leveraging big data, machine learning, and predictive modeling for generating more dynamic RWE and registries; and
- Partnering with providers and other stakeholders to provide clinical decision support and to demonstrate value.